These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 19903147)
1. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis. González PA; Bueno SM; Riedel CA; Kalergis AM Curr Med Chem; 2009; 16(34):4609-25. PubMed ID: 19903147 [TBL] [Abstract][Full Text] [Related]
3. The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development. Garg R; Shrivastava P; van Drunen Littel-van den Hurk S Expert Rev Vaccines; 2012 Dec; 11(12):1441-57. PubMed ID: 23252388 [TBL] [Abstract][Full Text] [Related]
5. Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection. Jung HE; Kim TH; Lee HK Viruses; 2020 Jan; 12(1):. PubMed ID: 31952261 [TBL] [Abstract][Full Text] [Related]
6. In vitro model for the assessment of human immune responses to subunit RSV vaccines. Chirkova T; Ha B; Rimawi BH; Oomens AGP; Hartert TV; Anderson LJ PLoS One; 2020; 15(3):e0229660. PubMed ID: 32191728 [TBL] [Abstract][Full Text] [Related]
7. Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus. Ascough S; Paterson S; Chiu C Front Immunol; 2018; 9():323. PubMed ID: 29552008 [TBL] [Abstract][Full Text] [Related]
8. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Graham BS Immunol Rev; 2011 Jan; 239(1):149-66. PubMed ID: 21198670 [TBL] [Abstract][Full Text] [Related]
9. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity. Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397 [TBL] [Abstract][Full Text] [Related]
10. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells. Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098 [TBL] [Abstract][Full Text] [Related]
11. Mucosal vaccines against respiratory syncytial virus. Yang K; Varga SM Curr Opin Virol; 2014 Jun; 6():78-84. PubMed ID: 24794644 [TBL] [Abstract][Full Text] [Related]
12. The role of Th17 and Treg responses in the pathogenesis of RSV infection. Mangodt TC; Van Herck MA; Nullens S; Ramet J; De Dooy JJ; Jorens PG; De Winter BY Pediatr Res; 2015 Nov; 78(5):483-91. PubMed ID: 26267154 [TBL] [Abstract][Full Text] [Related]
15. New insights for development of a safe and protective RSV vaccine. Blanco JC; Boukhvalova MS; Shirey KA; Prince GA; Vogel SN Hum Vaccin; 2010 Jun; 6(6):482-92. PubMed ID: 20671419 [TBL] [Abstract][Full Text] [Related]
16. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology. Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317 [TBL] [Abstract][Full Text] [Related]
17. Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Bueno SM; González PA; Cautivo KM; Mora JE; Leiva ED; Tobar HE; Fennelly GJ; Eugenin EA; Jacobs WR; Riedel CA; Kalergis AM Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20822-7. PubMed ID: 19075247 [TBL] [Abstract][Full Text] [Related]
18. Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity. Sarkar I; Garg R; van Drunen Littel-van den Hurk S Vaccine; 2016 Sep; 34(42):5114-5124. PubMed ID: 27591951 [TBL] [Abstract][Full Text] [Related]
19. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein. Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590 [TBL] [Abstract][Full Text] [Related]
20. Passive and active immunization against respiratory syncytial virus for the young and old. Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]